Focus Financial Network Inc. Has $12.15 Million Position in UnitedHealth Group Incorporated $UNH

Focus Financial Network Inc. lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 9.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 38,941 shares of the healthcare conglomerate’s stock after selling 3,935 shares during the period. Focus Financial Network Inc.’s holdings in UnitedHealth Group were worth $12,149,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in UNH. GAMMA Investing LLC boosted its stake in shares of UnitedHealth Group by 56,142.1% in the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate’s stock valued at $4,344,586,000 after purchasing an additional 8,280,404 shares in the last quarter. Nuveen LLC bought a new position in shares of UnitedHealth Group in the first quarter valued at about $3,846,764,000. Vanguard Group Inc. lifted its position in UnitedHealth Group by 6.6% during the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock worth $47,519,620,000 after buying an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP grew its stake in shares of UnitedHealth Group by 10.6% during the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock valued at $13,537,859,000 after purchasing an additional 2,486,839 shares during the last quarter. Finally, National Bank of Canada FI grew its stake in shares of UnitedHealth Group by 137.8% during the first quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate’s stock valued at $859,518,000 after purchasing an additional 950,928 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

UNH has been the topic of several research analyst reports. HSBC reissued a “reduce” rating and set a $270.00 price target (down from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Sanford C. Bernstein boosted their price objective on UnitedHealth Group from $337.00 to $379.00 and gave the stock an “outperform” rating in a report on Friday, September 5th. Royal Bank Of Canada dropped their price objective on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. Morgan Stanley raised their price target on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research report on Friday, September 12th. Finally, Wall Street Zen cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Saturday, May 24th. Sixteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $358.95.

UnitedHealth Group Stock Up 0.5%

UNH opened at $341.46 on Thursday. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The company has a market capitalization of $309.25 billion, a P/E ratio of 14.79, a P/E/G ratio of 2.22 and a beta of 0.45. The stock has a fifty day moving average of $294.30 and a 200-day moving average of $367.06.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter in the previous year, the business posted $6.80 EPS. The firm’s revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be given a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date is Monday, September 15th. UnitedHealth Group’s payout ratio is currently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.